KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.02.

  • Vir Biotechnology's Asset Utilization Ratio fell 6928.67% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6928.67%. This contributed to the annual value of 0.04 for FY2024, which is 2252.21% up from last year.
  • Per Vir Biotechnology's latest filing, its Asset Utilization Ratio stood at 0.02 for Q3 2025, which was down 6928.67% from 0.02 recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Asset Utilization Ratio ranged from a high of 0.96 in Q1 2022 and a low of 0.02 during Q2 2025
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.06 (2023), whereas its average is 0.27.
  • Per our database at Business Quant, Vir Biotechnology's Asset Utilization Ratio surged by 190911.76% in 2022 and then tumbled by 9401.6% in 2023.
  • Over the past 5 years, Vir Biotechnology's Asset Utilization Ratio (Quarter) stood at 0.69 in 2021, then decreased by 10.11% to 0.62 in 2022, then plummeted by 92.96% to 0.04 in 2023, then grew by 17.81% to 0.05 in 2024, then crashed by 70.24% to 0.02 in 2025.
  • Its Asset Utilization Ratio stands at 0.02 for Q3 2025, versus 0.02 for Q2 2025 and 0.02 for Q1 2025.